Abstract
Since pancreatobiliary diversion probably stimulates pancreatic growth by increasing cholecystokinin secretion, the effect of the cholecystokinin antagonist CR-1409 on this adaptive response was tested. Male Wistar rats (n = 108) weighing 220-250g were randomised to receive either pancreatobiliary diversion (n = 60) or sham diversion (n = 48) and thereafter to receive either saline injections or CR-1409 (10 mg/kg/day, subcutaneously). Rats were killed at four, seven, and 14 days postoperatively, when blood was obtained for cholecystokinin assay and the pancreas was assessed for proliferative activity by three techniques: nucleic acid and protein assay, bromodeoxyuridine labelling, and metaphase arrest after vincristine administration (1 mg/kg, intraperitoneally). Pancreatobiliary diversion increased plasma cholecystokinin concentrations by 91% at seven days and 137% at 14 days, irrespective of CR-1409 treatment. Total pancreatic RNA content was doubled by pancreatobiliary diversion at four days (2.15 v 1.07 mg/100 g body weight: p less than 0.001) and at seven days (3.43 v 1.76 mg/100 g: p less than 0.001), and trebled at 14 days (4.27 v 1.32 mg/100 g: p less than 0.001). Pancreatobiliary diversion increased bromodeoxyuridine labelling index from 1.1 to 3.7% at seven days and the cell birth rate from 0.09 to 0.06%. CR-1409 completely abolished this proliferative response and partly prevented the rise in RNA. The results confirm pancreatic hypertrophy and increased acinar cell proliferation after pancreatobiliary diversion. CR-1409 prevents this adaptive growth, probably by blocking cholecystokinin receptors. Bromodeoxyuridine labelling and the metaphase arrest technique may be used to assess pancreatic cell kinetics.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appleton G. V., Bristol J. B., Williamson R. C. Proximal enterectomy provides a stronger systemic stimulus to intestinal adaptation than distal enterectomy. Gut. 1987;28 (Suppl):165–168. doi: 10.1136/gut.28.suppl.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boer G. J. A simplified microassay of DNA and RNA using ethidium bromide. Anal Biochem. 1975 May 12;65(1-2):225–231. doi: 10.1016/0003-2697(75)90507-2. [DOI] [PubMed] [Google Scholar]
- Davidson P. M., Campbell I. L., Oxbrow L., Hutson J. M., Harrison L. C. Pancreatic beta cell proliferation in rabbits demonstrated by bromodeoxyuridine labeling. Pancreas. 1989;4(5):594–600. doi: 10.1097/00006676-198910000-00011. [DOI] [PubMed] [Google Scholar]
- Eysselein V. E., Eberlein G. A., Hesse W. H., Singer M. V., Goebell H., Reeve J. R., Jr Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J Biol Chem. 1987 Jan 5;262(1):214–217. [PubMed] [Google Scholar]
- Fölsch U. R., Creutzfeldt W. Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man. Scand J Gastroenterol Suppl. 1985;112:54–63. doi: 10.3109/00365528509092213. [DOI] [PubMed] [Google Scholar]
- Imamura Y., Sugihara H., Miyake T., Ikeda T., Noriki S., Miyoshi N., Nakanishi K., Fukuda M. Lectin histochemistry in rat thyroid tumours. Basic Appl Histochem. 1989;33(3):185–196. [PubMed] [Google Scholar]
- JU J. S., NASSET E. S. Changes in total nitrogen content of some abdominal viscera in fasting and realimentation. J Nutr. 1959 Aug 10;68(4):633–645. doi: 10.1093/jn/68.4.633. [DOI] [PubMed] [Google Scholar]
- Le Pecq J. B., Paoletti C. A new fluorometric method for RNA and DNA determination. Anal Biochem. 1966 Oct;17(1):100–107. doi: 10.1016/0003-2697(66)90012-1. [DOI] [PubMed] [Google Scholar]
- Malfertheiner P., Büchler M., Glasbrenner B., Schafmayer A., Ditschuneit H. Adaptive changes of the exocrine pancreas and plasma cholecystokinin release following subtotal gastric resection in rats. Digestion. 1987;38(3):142–151. doi: 10.1159/000199583. [DOI] [PubMed] [Google Scholar]
- Miazza B. M., Widgren S., Chayvialle J. A., Nicolet T., Loizeau E. Exocrine pancreatic nodules after longterm pancreaticobiliary diversion in rats. An effect of raised CCK plasma concentrations. Gut. 1987;28 (Suppl):269–273. doi: 10.1136/gut.28.suppl.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagy I., Pap A., Varró V. Time-course of changes in pancreatic size and enzyme composition in rats during starvation. Int J Pancreatol. 1989 Jul;5(1):35–45. doi: 10.1007/BF02925696. [DOI] [PubMed] [Google Scholar]
- Niederau C., Liddle R. A., Williams J. A., Grendell J. H. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut. 1987;28 (Suppl):63–69. doi: 10.1136/gut.28.suppl.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Savage A. P., Gornacz G. E., Adrian T. E., Ghatei M. A., Goodlad R. A., Wright N. A., Bloom S. R. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut. 1985 Dec;26(12):1353–1358. doi: 10.1136/gut.26.12.1353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stace N. H., Palmer T. J., Vaja S., Dowling R. H. Longterm pancreaticobiliary diversion stimulates hyperplastic and adenomatous nodules in the rat pancreas: a new model for spontaneous tumour formation. Gut. 1987;28 (Suppl):265–268. doi: 10.1136/gut.28.suppl.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart I. D., Flaks B., Watanapa P., Davies P. W., Williamson R. C. Pancreatobiliary diversion enhances experimental pancreatic carcinogenesis. Br J Cancer. 1991 Jan;63(1):63–66. doi: 10.1038/bjc.1991.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stock-Damgé C., Aprahamian M., Lhoste E., Pousse A., Humbert W., Noriega R., Grenier J. F. Pancreatic hyperplasia after small bowel resection in the rat: dissociation from endogenous gastrin levels. Digestion. 1984;29(4):223–230. doi: 10.1159/000199037. [DOI] [PubMed] [Google Scholar]
- Tatsuta M., Iishi H., Baba M., Taniguchi H. Effect of ornithine decarboxylase inhibitor on tetragastrin treatment of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer. 1990 Feb 15;45(2):308–311. doi: 10.1002/ijc.2910450217. [DOI] [PubMed] [Google Scholar]
